Han has a background of leading a consumer intelligence company called MetrixLab from start to public exit as founder, CEO and Board Member. Han founded MetrixLab in 1999 and expanded the company into multiple countries in- and outside of Europe. To speed up MetrixLab’s growth he successfully executed six acquisitions. In 2014 Han merged MetrixLab with MacroMill into a leading marketing tech company with +300M in annual revenue, 1800 employees and 30 offices worldwide. After the merger the companies continued under the ‘Macromill Group’ brand of which Han became global CEO until late 2015. Han remained Board Member until late 2016 and shareholder until the company went public on the Tokyo Stock Exchange in 2017. Han is also founder of VOC Capital Partners and Stadswaarde through which he invests in technology related companies and real estate respectively. Since 2017 Han is also an active investor in the field of Life Sciences and by co-founding Curie Capital in 2018 he looks to expand his activities in this fast developing field.
Mariette has an extensive background in the field of Life Sciences as she has 23 years of experience working for and with international companies developing and selling new medical technologies and medicines. During these years Mariette gained in depth experience and expertise in the field through a broad range of companies and products. From 2013 until 2018 Mariette was Senior Investment Manager Life Sciences & Health at the Brabantse Ontwikkelings Maatschappij (BOM). Here Mariette was responsible for the management of up to 13 portfolio companies where she represented the BOM as shareholder and, to a number of these companies, as Board Member. Before working as a Life Science investor, Mariette had 17 years of all round management and business development experience in biotech. This includes being highly involved in many innovative start-up ventures and the international launch of innovative products. In 2017 Mariette founded Curiant, through which she gives investment related consultancy to early stage companies and investors within the field of Life Sciences. By co-founding Curie Capital in 2018 Mariette uses her broad knowledge and experience in the Life Sciences field to invest in early stage start-ups.
Olivier complements the Curie Capital founding team as our analyst. Besides working for Curie Capital, Olivier is finishing up a second BSc degree in Nanobiology at the TU Delft after having completed a BSc degree in Medicine at the Erasmus University in Rotterdam. Before co-creating Curie Capital, Olivier was working on the biotechnology portfolio of Han de Groot’s family office for over a year and did a summer internship at a leading life sciences-focused investment firm in London.